Program Overview
Leading researchers and clinicians in the field of lupus will discuss the advances in management and treatment of lupus. Topics covered, include:
- Advances in Pathogenesis and Genetics
- Lupus Outcomes: Bones, Heart, Cancer
- State of Lupus Treatment
Target Audience
This activity is designed to meet the continuing educational needs of specialists in rheumatology, immunology, internal medicine and family practice. Physician Assistants may also benefit from this activity.
Learning Objectives
At the conclusion of this activity, participants should be able to:
- Discuss the challenges of diagnosing lupus and how we define the disease.
- Identify the key advances in our understanding of lupus pathogenesis.
- Articulate and describe the most current research in lupus genetics.
- Identify the risk factors for bone loss and the approaches to prevention and management in patients with lupus.
- Identify the risk factors for premature heart disease in lupus and the suggested management strategies.
- Identify the risk factors for cancer in patients with lupus.
- Discuss the approach to treatment of lupus.
- Describe the rationale and evidence to support the use of biologic therapies in lupus.
Activity Goal
This activity is designed to address the following ABMS / IOM competencies: Patient Care and Medical Knowledge.
Agenda
| 7:30 - 8:00 a.m. | Registration and Continental Breakfast | |
| 8:00 - 8:10 a.m. | Welcome and Introduction | |
| 8:10 - 9:10 a.m. | How did we get here? Advances in our Understanding of Lupus Pathogenesis and Genetics | |
| 9:10 - 10:00 a.m. | Lupus Outcomes: Bones, Heart and Cancer | |
| 10:00 - 10:15 a.m. | Break | |
| 10:15 - 11:15 a.m. | State of Lupus Treatment | |
| 11:15 - 12:00 p.m. | Q&A and Evaluation |
Disclaimer
The information provided at this CME activity is for continuing medical education purposes only and is not meant to substitute the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient's medical condition.
Accreditation
This educational activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Ciné-Med and the Lupus Foundation of America. Ciné-Med is accredited by the ACCME to provide continuing medical education for physicians.
Ciné-Med designates this live activity for a maximum of 3.75 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Commercial Support
This CME activity is supported by educational grants. A complete list of supporters will be published in the program book.